APPLICATION
ANDA212706
TYPE
ANDA
ORIGINAL APPROVAL
2020-12-18
LATEST ACTION
2023-09-22
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription
Products
MERZEEPrescription
ETHINYL ESTRADIOL 0.02MG, NORETHINDRONE ACETATE 1MG · CAPSULE · ORAL
Approval history
2023-09-22Labeling · Supplement 2 · standardAP
2023-09-22Labeling · Supplement 1 · standardAP
2020-12-18UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.